Business · 04/01/2007Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Obesity Management in Dogs
Summary
The US Food and Drug Administration (FDA) has amended its regulations to reflect the approval of a new animal drug application (NADA) filed by Pfizer, Inc. for the use of dirlotapide solution in dogs to manage obesity.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →